RxDoctor Payments Data

David Regalla, PA

Physician Assistant · Greensburg, PANPI 1982661468

Payments from drug & device makers

$1,125in general payments, 2019–2025

Across 62 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$262
  • Eisai Inc.$131
  • MDD US Operations, LLC$116
  • Pfizer$94
  • Amneal Pharmaceuticals LLC$76
  • SK Life Science, Inc.$68
  • plus $378 from 13 others

What the payments were for

  • Food & beverage$1,125100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,125 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,960
Medicare patients
19
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5011$153,978
Droxidopa12$110,199
Nurtec OdtRimegepant Sulfate92$106,664
Aimovig AutoinjectorErenumab-Aooe85$76,194
UbrelvyUbrogepant76$75,678
QuliptaAtogepant52$64,435
Dimethyl Fumarate22$60,689
NuedextaDextromethorphan Hbr/Quinidine25$59,370
Emgality PenGalcanezumab-Gnlm80$55,450
LamictalLamotrigine41$53,361
OnfiClobazam11$48,676
KeppraLevetiracetam21$39,082
Gamunex-CImmune Globul G/Gly/Iga Avg 4613$36,526
Dalfampridine ErDalfampridine20$27,159
Lacosamide185$24,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$262$140,113128 claims
PfizerNurtec Odt, Lyrica, Dilantin$94$127,228147 claims
Lundbeck LLCOnfi$20$48,67611 claims
UCB, Inc.Neupro, Vimpat$43$42,82930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Greensburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →